Trends in resource utilisation and prescription of anticonvulsants for patients with active epilepsy in Germany 2003 to 2013 - a ten year overview
Willems LM, Richter S, Watermann N, Bauer S, Klein KM, Reese JP, Schöffski O, Hamer HM, Knake S, Rosenow F, Strzelczyk A (2018)
Publication Type: Journal article
Publication year: 2018
Journal
Book Volume: 83
Pages Range: 28-35
DOI: 10.1016/j.yebeh.2018.03.025
Abstract
Abstract
This study evaluated trends in resource use and prescription patterns in patients with active epilepsy over a 10-year period at the same outpatient clinic of a German epilepsy center. We analyzed a cross-sectional patient sample of consecutive adults with active epilepsy over a 3-month period in 2013 and compared them with equally acquired data from the years 2003 and 2008. Using validated patient questionnaires, data on socioeconomic status, course of epilepsy, as well as direct and indirect costs were recorded. A total of 198 patients (mean age: 39.6±15.0years, 49.5% male) were enrolled and compared with our previous assessments in 2003 (n=101) and 2008 (n=151). In the 2013 cohort, 75.8% of the patients had focal epilepsy, and the majority were taking antiepileptic drugs (AEDs) (39.9% monotherapy, 59.1% polytherapy). We calculated epilepsy-specific costs of €3674 per three months per patient. Direct medical costs were mainly due to anticonvulsants (20.9% of total direct costs) and to hospitalization (20.8% of total direct costs). The proportion of enzyme-inducing anticonvulsants and 'old' AEDs decreased between 2003 and 2013. Indirect costs of €1795 in 2013 were mainly due to early retirement (55.0% of total indirect costs), unemployment (26.5%), and days off due to seizures (18.2%). In contrast to our previous findings from 2003 and 2008, our data show a stagnating cost increase with slightly reduced total costs and balanced direct and indirect costs in patients with active epilepsy. These findings are accompanied by an ongoing cost-neutral increase in the prescription of 'newer' and non-enzyme-inducing AEDs. However, the number and distribution of indirect cost components remained unchanged.
Authors with CRIS profile
Involved external institutions
Germany (DE)How to cite
APA:
Willems, L.M., Richter, S., Watermann, N., Bauer, S., Klein, K.M., Reese, J.P.,... Strzelczyk, A. (2018). Trends in resource utilisation and prescription of anticonvulsants for patients with active epilepsy in Germany 2003 to 2013 - a ten year overview. Epilepsy and Behavior, 83, 28-35. https://doi.org/10.1016/j.yebeh.2018.03.025
MLA:
Willems, Laurent M., et al. "Trends in resource utilisation and prescription of anticonvulsants for patients with active epilepsy in Germany 2003 to 2013 - a ten year overview." Epilepsy and Behavior 83 (2018): 28-35.
BibTeX: Download